RAIsonance, Inc.
RAIsonance is an AI Healthtech company leveraging advanced artificial intelligence to interpret human cough sounds for respiratory health screening, monitoring, and diagnostics. Their mission is to support and improve human respiratory health through innovative, accessible, and scalable solutions. They develop products for respiratory disease screening, wellness monitoring, chronic respiratory support, and diagnostic platforms for diseases like COVID-19, Tuberculosis, Influenza, and RSV.
Industries
Nr. of Employees
small (1-50)
RAIsonance, Inc.
Greenwood Village, Colorado, United States, North America
Products
Cough-based respiratory screening SaMD
Cloud-based software that analyzes short forced cough recordings to screen for specific respiratory diseases and provide clinical decision support for follow-up testing.
Enterprise Test Management Portal
Web-based portal for bulk acquisition, distribution, monitoring and reporting of screening workflows and results; includes dashboards for high-volume customers.
Population early-warning monitoring (FCV Sentinel)
Threat-agnostic monitoring system that tracks changes in individual FCV signatures and reports aggregate impact scores to detect potential health events across groups.
Personal respiratory wellness mobile apps (baseline tracking and scoring)
Mobile applications that create per-user cough baselines and provide improvement or impairment scores over time, with symptom diaries to support smoking/vape cessation and Long COVID monitoring.
Cough-based biometric authentication and access control
Non-medical biometric suite that authenticates users by comparing a new forced cough recording to a stored baseline and issues short-lived QR tokens for verified access.
Air quality human impact monitoring program
Program that pairs daily cough-based biometric data with third-party air quality datasets to assess human respiratory impact and generate alerts and dashboards.
Cough-based respiratory screening SaMD
Cloud-based software that analyzes short forced cough recordings to screen for specific respiratory diseases and provide clinical decision support for follow-up testing.
Enterprise Test Management Portal
Web-based portal for bulk acquisition, distribution, monitoring and reporting of screening workflows and results; includes dashboards for high-volume customers.
Population early-warning monitoring (FCV Sentinel)
Threat-agnostic monitoring system that tracks changes in individual FCV signatures and reports aggregate impact scores to detect potential health events across groups.
Personal respiratory wellness mobile apps (baseline tracking and scoring)
Mobile applications that create per-user cough baselines and provide improvement or impairment scores over time, with symptom diaries to support smoking/vape cessation and Long COVID monitoring.
Cough-based biometric authentication and access control
Non-medical biometric suite that authenticates users by comparing a new forced cough recording to a stored baseline and issues short-lived QR tokens for verified access.
Air quality human impact monitoring program
Program that pairs daily cough-based biometric data with third-party air quality datasets to assess human respiratory impact and generate alerts and dashboards.
Services
Clinical validation and study execution
Designs and executes multi-site prospective and retrospective validation studies comparing cough-based SaMD outputs to laboratory/molecular and imaging reference standards; conducts usability studies.
Enterprise deployment and integration services
Onboards and supports distributor partnerships, configures enterprise portals for bulk test distribution and dashboard monitoring, and integrates results reporting with public health workflows.
Workforce wellness program implementation
Implements population wellness monitoring programs using FCV Sentinel and personalized wellness applications, with dashboards and configurable group-level readiness reporting.
Regulatory and quality support for SaMD
Prepares regulatory submissions and supporting clinical evidence for Software as a Medical Device, and coordinates compliance activities tied to government contracts and grants.
Clinical validation and study execution
Designs and executes multi-site prospective and retrospective validation studies comparing cough-based SaMD outputs to laboratory/molecular and imaging reference standards; conducts usability studies.
Enterprise deployment and integration services
Onboards and supports distributor partnerships, configures enterprise portals for bulk test distribution and dashboard monitoring, and integrates results reporting with public health workflows.
Workforce wellness program implementation
Implements population wellness monitoring programs using FCV Sentinel and personalized wellness applications, with dashboards and configurable group-level readiness reporting.
Regulatory and quality support for SaMD
Prepares regulatory submissions and supporting clinical evidence for Software as a Medical Device, and coordinates compliance activities tied to government contracts and grants.
Expertise Areas
- AI/ML bioacoustics for respiratory health
- Clinical study design and diagnostic validation
- Digital health SaMD development
- Biometric authentication using audio signatures
Key Technologies
- Forced cough vocalization (FCV) analysis
- Spectrogram-based signal processing
- Deep learning ensemble models
- Transfer learning